ABMD Abiomed Inc

Price (delayed)

$285.92

Market cap

$12.93B

P/E Ratio

64.4

Dividend/share

N/A

EPS

$4.44

Enterprise value

$12.75B

Sector: Healthcare
Industry: Medical Devices

Abiomed is a publicly-traded medical devices company that develops and manufactures the circulatory support device Impella, the world’s smallest heart pump. The company is headquartered in Danvers, Massachusetts and has ...

Highlights

Abiomed's equity has increased by 20% YoY and by 7% from the previous quarter
ABMD's P/E is 19% below its 5-year quarterly average of 79.5 but 10% above its last 4 quarters average of 58.6
ABMD's quick ratio is down by 18% since the previous quarter but it is up by 15% year-on-year
The net income has contracted by 18% YoY and by 3.5% from the previous quarter
ABMD's EPS is down by 18% year-on-year and by 3.5% since the previous quarter

Key stats

What are the main financial stats of ABMD
Market
Shares outstanding
45.23M
Market cap
$12.93B
Enterprise value
$12.75B
Valuations
Price to earnings (P/E)
64.4
Price to book (P/B)
10.24
Price to sales (P/S)
15.9
EV/EBIT
50.19
EV/EBITDA
45.98
EV/Sales
15.69
Earnings
Revenue
$812.94M
EBIT
$254.04M
EBITDA
$277.31M
Free cash flow
$236.88M
Per share
EPS
$4.44
Free cash flow per share
$5.24
Book value per share
$27.91
Revenue per share
$17.98
TBVPS
$28.88
Balance sheet
Total assets
$1.43B
Total liabilities
$166.99M
Debt
$0
Equity
$1.26B
Working capital
$573.29M
Liquidity
Debt to equity
0
Current ratio
5.76
Quick ratio
4.81
Net debt/EBITDA
-0.65
Margins
EBITDA margin
34.1%
Gross margin
80.9%
Net margin
24.7%
Operating margin
27.7%
Efficiency
Return on assets
15.4%
Return on equity
17.4%
Return on invested capital
27.9%
Return on capital employed
19.4%
Return on sales
31.2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ABMD stock price

How has the Abiomed stock price performed over time
Intraday
-5.08%
1 week
-11.82%
1 month
-12.26%
1 year
82.02%
YTD
-11.81%
QTD
-11.81%

Financial performance

How have Abiomed's revenue and profit performed over time
Revenue
$812.94M
Gross profit
$657.74M
Operating income
$224.81M
Net income
$200.47M
Gross margin
80.9%
Net margin
24.7%
The net income has contracted by 18% YoY and by 3.5% from the previous quarter
ABMD's net margin is down by 15% year-on-year and by 4.6% since the previous quarter
The company's operating income fell by 12% YoY
Abiomed's operating margin has decreased by 9% YoY

Growth

What is Abiomed's growth rate over time

Valuation

What is Abiomed stock price valuation
P/E
64.4
P/B
10.24
P/S
15.9
EV/EBIT
50.19
EV/EBITDA
45.98
EV/Sales
15.69
ABMD's P/E is 19% below its 5-year quarterly average of 79.5 but 10% above its last 4 quarters average of 58.6
ABMD's EPS is down by 18% year-on-year and by 3.5% since the previous quarter
ABMD's P/B is 22% below its 5-year quarterly average of 13.2 but 8% above its last 4 quarters average of 9.5
Abiomed's equity has increased by 20% YoY and by 7% from the previous quarter
The price to sales (P/S) is 15% higher than the last 4 quarters average of 13.8
The company's revenue fell by 3.4% YoY

Efficiency

How efficient is Abiomed business performance
ABMD's return on equity is down by 30% year-on-year and by 8% since the previous quarter
Abiomed's ROA has decreased by 29% YoY and by 8% from the previous quarter
The ROIC has contracted by 24% YoY and by 8% from the previous quarter
ABMD's return on sales is down by 17% year-on-year and by 7% since the previous quarter

Dividends

What is ABMD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ABMD.

Financial health

How did Abiomed financials performed over time
Abiomed's total assets has increased by 19% YoY and by 8% from the previous quarter
ABMD's quick ratio is down by 18% since the previous quarter but it is up by 15% year-on-year
ABMD's debt is 100% smaller than its equity
Abiomed's equity has increased by 20% YoY and by 7% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.